Solid Biosciences Ownership | Who Owns Solid Biosciences?
Solid Biosciences Ownership Summary
Solid Biosciences is owned by 4.25% institutional investors, 0.52% insiders, and 95.23% retail investors. Perceptive advisors is the largest institutional shareholder, holding 17.95% of SLDB shares. Fidelity Select Biotechnology is the top mutual fund, with 4.09% of its assets in Solid Biosciences shares.
SLDB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Solid Biosciences | 4.25% | 0.52% | 95.23% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Perceptive advisors | 11.91M | 17.95% | $57.99M |
| Bain capital life sciences investors | 7.91M | 11.93% | $38.53M |
| Siren | 7.42M | 11.18% | $36.12M |
| Adage capital partners gp | 6.73M | 10.14% | $32.77M |
| Ra capital management | 5.81M | 8.76% | $28.30M |
| Blackrock funding, inc. /de | 4.92M | 5.23% | $23.96M |
| Monashee investment management | 2.17M | 3.26% | $10.54M |
| Redmile group | 1.92M | 2.89% | $9.33M |
| Nantahala capital management | 1.70M | 2.57% | $8.30M |
| Bioimpact capital | 1.63M | 2.46% | $7.96M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bain capital life sciences investors | 7.91M | 4.82% | $38.53M |
| Monashee investment management | 2.17M | 3.82% | $10.54M |
| Ally bridge group (ny) | 724.00K | 2.93% | $3.53M |
| Perceptive advisors | 11.91M | 2.15% | $57.99M |
| Siren | 7.42M | 1.87% | $36.12M |
| Bioimpact capital | 1.63M | 1.38% | $7.96M |
| Sectoral asset management | 421.58K | 1.36% | $2.05M |
| Redmile group | 1.92M | 0.99% | $9.33M |
| Birchview capital, lp | 178.77K | 0.86% | $870.60K |
| Ra capital management | 5.81M | 0.48% | $28.30M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 4.92M | 0.00% | 2.77M |
| Ra capital management | 5.81M | 0.48% | 1.48M |
| Nantahala capital management | 1.70M | 0.33% | 1.42M |
| Point72 asset management | 1.27M | 0.01% | 1.06M |
| Ally bridge group (ny) | 724.00K | 2.93% | 724.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Commodore capital lp | - | - | -5.83M |
| Vr adviser | - | - | -2.48M |
| Casdin capital | - | - | -775.00K |
| Ecor1 capital | - | - | -744.45K |
| Silverarc capital management | - | - | -452.24K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ally bridge group (ny) | 724.00K | 2.93% | 724.00K | $3.53M |
| Sectoral asset management | 421.58K | 1.36% | 421.58K | $2.05M |
| Armistice capital | 400.00K | 0.03% | 400.00K | $1.95M |
| Bollard group | 361.66K | 0.04% | 361.66K | $1.76M |
| Blair william & co/il | 165.70K | 0.00% | 165.70K | $806.96K |
Sold Out
| Holder | Change |
|---|---|
| Gamma investing | -153.00 |
| Coldstream capital management | -685.00 |
| Smartleaf asset management | -800.00 |
| Belvedere trading | -901.00 |
| Simplex trading | -1.09K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 24 | -81.10% | 2,819,669 | -96.42% | 4 | 0.03% | 17 | -81.32% | 3 | -82.35% |
| Mar 31, 2025 | 127 | 33.68% | 78,847,007 | 117.02% | 193 | 2.44% | 91 | 78.43% | 17 | -5.56% |
| Dec 31, 2024 | 1 | - | 7 | - | - | - | - | - | - | - |
| Sep 30, 2024 | 1 | - | 7 | - | - | - | - | -100.00% | - | - |
| Jun 30, 2024 | 1 | - | 7 | 16.67% | - | - | 1 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Select Biotechnology | 3.17M | 4.09% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.87M | 2.41% | -41.42K |
| iShares Russell 2000 ETF | 1.55M | 2.00% | -29.50K |
| Franklin Biotechnology Discv A(acc)USD | 1.03M | 1.33% | - |
| Vanguard US Total Market Shares ETF | 854.68K | 1.12% | - |
| Fidelity Small Cap Index | 663.26K | 0.85% | 421.06K |
| Vanguard Institutional Extnd Mkt Idx Tr | 642.62K | 0.83% | -299.52K |
| International Biotechnology Ord | 582.01K | 0.75% | - |
| iShares Russell 2000 Value ETF | 569.18K | 0.73% | 422.00 |
| Franklin Biotechnology Discovery A | 566.70K | 0.73% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 11, 2025 | Kahn Clare | - | Buy | $9.92K |
| Feb 19, 2025 | Bain Capital Life Sciences Investors, LLC | - | Buy | $4.03M |
| Feb 19, 2025 | Bain Capital Life Sciences Investors, LLC | - | Buy | $6.44K |
| Feb 19, 2025 | PERCEPTIVE ADVISORS LLC | Buy | $20.15M | |
| Feb 19, 2025 | RA CAPITAL MANAGEMENT, L.P. | - | Buy | $3.72K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | 6 | 10 |
| 2024 Q4 | - | 5 |
| 2024 Q3 | - | - |
SLDB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools